SelectImmune Pharma AB
ABDissolvedOrg 5591046874Other research and experimental development on natural sciences and engineering· NACE 7219Est. 2017 · 9 years old2 employees
Loading company…
| EBITDA |
| −3 932 |
| −8 164 |
| −12 244 |
| −13 682 |
| −8 233 |
| Depreciation & amort. | −0 | −76 | −399 | −399 | −399 |
| EBIT | −3 932 | −8 240 | −12 643 | −14 081 | −8 632 |
| Net financials | — | — | — | — | 15 |
| Profit before tax | −3 932 | −8 240 | −12 643 | −14 081 | −8 617 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 932 | −8 240 | −12 643 | −14 081 | −8 617 |
| Long-term debt |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| Short-term debt | 5 651 | 712 | 3 019 | 1 221 | 1 959 |
| Total debt | 5 651 | 712 | 3 019 | 1 221 | 1 959 |